Noboru Oishi

1.1k total citations
45 papers, 839 citations indexed

About

Noboru Oishi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Noboru Oishi has authored 45 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Noboru Oishi's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Noboru Oishi is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Noboru Oishi collaborates with scholars based in United States, Japan and Iran. Noboru Oishi's co-authors include Harry A. Crissman, J J Costanzi, H. Samuel Wieand, Bernard Fisher, Philip H. Gordon, S Legault-Poisson, Peter J. Deckers, Norman Wolmark, Peter R. Jochimsen and Harvey J. Lerner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Noboru Oishi

45 papers receiving 759 citations

Peers

Noboru Oishi
Comparison fields: 5 of 104
  • Oncology 306
  • Pulmonary and Respiratory Medicine 184
  • Molecular Biology 180
  • Surgery 150
  • Genetics 99
Replace Robert W. McGuffin with:
Robert W. McGuffin United States
Clifton D. Howe United States
Yohko Murakawa Japan
R. Kubota Japan
Amarnath Jena India
J. Allan Tucker United States
Vijay Varma United States
Richard Huijbens Netherlands
Alton C. Morgan United States
Frederick H. Davidorf United States
Robert W. McGuffin United States View profile →
Citations per field, relative to Noboru Oishi
Noboru Oishi · 1×
Citations per year, relative to Noboru Oishi
Noboru Oishi · 1×

Countries citing papers authored by Noboru Oishi

Since Specialization
Citations

This map shows the geographic impact of Noboru Oishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Oishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Oishi more than expected).

Fields of papers citing papers by Noboru Oishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noboru Oishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Oishi. The network helps show where Noboru Oishi may publish in the future.

Co-authorship network of co-authors of Noboru Oishi

This figure shows the co-authorship network connecting the top 25 collaborators of Noboru Oishi. A scholar is included among the top collaborators of Noboru Oishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noboru Oishi. Noboru Oishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 6
2 63
3 15
4 11
5 2
6 21
7 3
8 21
9 2
10 8
11 3
12 14
13 1
14
Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
2
15
Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.
9
16
Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
2
17 154
18 3
19
Studies on ADP-induced platelet aggregation in normal and diseased groups.
3
20 38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026